Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2021 Jul 06; Vol. 10 (13), pp. e021084. Date of Electronic Publication: 2021 May 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT.

  • Authors : Beddhu S; 1 Medical Service Veterans Affairs Salt Lake City Health Care System Salt Lake City UT.; 2 Division of Nephrology & Hypertension University of Utah School of Medicine Salt Lake City UT.

Subjects: Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*administration & dosage ; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2018 Sep 18; Vol. 7 (18), pp. e009326.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.

  • Authors : Patorno E; Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Gopalakrishnan C

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*epidemiology

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Apr; Vol. 20 (4), pp. 974-984. Date of Electronic Publication: 2018 Jan 12.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction.

  • Authors : Adamek KE; 1 Department of Medicine University of Colorado School of Medicine Aurora CO.; Ramadurai D

Subjects: Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/*therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/Angiotensin-Converting Enzyme Inhibitors/*therapeutic use ; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2019 Feb 05; Vol. 8 (3), pp. e011448.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Outcomes of "diabetes-friendly" vs "diabetes-unfriendly" β-blockers in older nursing home residents with diabetes after acute myocardial infarction.

  • Authors : Zullo AR; Department of Health Services, Policy, and Practice, Brown University School of Public Health, Providence, Rhode Island.; Department of Pharmacy, Rhode Island Hospital, Providence, Rhode Island.

Subjects: Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/Adrenergic beta-Antagonists/*pharmacology ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Dec; Vol. 20 (12), pp. 2724-2732. Date of Electronic Publication: 2018 Jul 22.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus.

  • Authors : Kothny W; Novartis Pharmaceuticals, East Hanover, NJ 07936, USA. ; Foley J

Subjects: Adamantane/Adamantane/Adamantane/*analogs & derivatives ; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2013 Mar; Vol. 15 (3), pp. 252-7. Date of Electronic Publication: 2012 Nov 01.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Dapagliflozin monotherapy in drug-naïve patients with diabetes: a randomized-controlled trial of low-dose range.

  • Authors : Bailey CJ; Life and Health Sciences, Aston University, Birmingham, UK. ; Iqbal N

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glucosides/Glucosides/Glucosides/*therapeutic use

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2012 Oct; Vol. 14 (10), pp. 951-9. Date of Electronic Publication: 2012 Jul 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Greater fear of hypoglycaemia with premixed insulin than with basal-bolus insulin glargine and glulisine: patient-reported outcomes from a 60-week randomised study.

  • Authors : Polonsky WH; Department of Psychiatry, University of California and Behavioral Diabetes Institute, San Diego, CA, USA.; Thompson S

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemia/Hypoglycemia/Hypoglycemia/*chemically induced

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2014 Nov; Vol. 16 (11), pp. 1121-7. Date of Electronic Publication: 2014 Jul 12.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited

Record details

×
Academic Journal

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

Subjects: Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glyburide/Glyburide/Glyburide/*therapeutic use

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2002 May; Vol. 4 (3), pp. 201-8.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print Cited Medium: Print

Record details

×
Academic Journal

Bariatric surgery: unstressing or boosting the beta-cell?

Subjects: Bariatric Surgery/Bariatric Surgery/Bariatric Surgery/*methods ; Blood Glucose/Blood Glucose/Blood Glucose/*physiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*metabolism

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2009 Nov; Vol. 11 Suppl 4, pp. 130-42.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print Cited Medium:

Record details

×
  • 1-10 of  34 results for ""Blood Glucose""